Sarepta Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY1980 | — | — | $0 |
| FY2008 | — | — | $11.2M |
| FY2009 | — | — | $48.3M |
| FY2010 | $48.8M | $46.0M | $33.6M |
| FY2011 | $23.4M | $54.4M | $39.9M |
| FY2012 | $81.3M | $205.0M | $187.7M |
| FY2013 | $44.4M | $291.6M | $257.0M |
| FY2014 | $47.4M | $295.0M | $73.6M |
| FY2015 | $83.4M | $273.8M | $80.3M |
| FY2016 | $87.4M | $424.1M | $122.4M |
| FY2017 | $518.7M | $1.31B | $599.7M |
| FY2018 | $609.8M | $1.64B | $370.8M |
| FY2019 | $1.00B | $1.82B | $835.1M |
| FY2020 | $2.22B | $2.98B | $1.50B |
| FY2021 | $2.22B | $3.15B | $2.12B |
| FY2022 | $2.74B | $3.13B | $966.8M |
| FY2023 | $2.41B | $3.26B | $428.4M |
| FY2024 | $2.44B | $3.96B | $1.10B |
| FY2025 | $2.21B | $3.35B | $801.3M |